Predicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional study.
Predicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional study.
复制标题
预测坦桑尼亚接受抗逆转录病毒治疗的 HIV-1 感染儿童的病毒学失败:一项横断面研究。
DOI:
10.1097/qai.0b013e3181cf4882
复制
发表时间:
2010-08
期刊:
影响因子:
--
通讯作者:
Reddy EA
中科院分区:
文献类型:
--
作者:
Emmett SD;Cunningham CK;Mmbaga BT;Kinabo GD;Schimana W;Swai ME;Bartlett JA;Crump JA;Reddy EA
Many HIV care and treatment programs in resource-limited settings rely on clinical and immunologic monitoring of antiretroviral therapy (ART), but accuracy of this strategy to detect virologic failure (VF) among children has not been evaluated. A cross sectional sample of HIV-infected children aged 1-16 years on ART ≥6 months receiving care at a Tanzanian referral center underwent clinical staging, CD4 lymphocyte measurement, plasma HIV-1 RNA level, and complete blood count (CBC). Associations with VF (HIV RNA ≥400 copies/mL) were determined utilizing bivariable and multivariate analyses; accuracy of current clinical and immunologic guidelines in identifying children with VF was assessed. Of 206 children (median age 8.7 years, ART duration 2.4 years), 65 (31.6%) demonstrated VF at enrollment. Clinical and immunological criteria identified 2 (3.5%) of 57 children with VF on first-line therapy, exhibiting 3.5% sensitivity and 100% specificity. VF was associated with younger age, receipt of nevirapine vs. efavirenz-based regimen, CD4% <25%, and physician documentation of maladherence (p<0.05 on bivariable analysis); the latter two factors remained significant on multivariate logistic regression. This study demonstrates poor performance of clinical and immunologic criteria in identifying children with virologic failure. Affordable techniques for measuring HIV-1 RNA level applicable in resource-limited settings are urgently needed.